Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience-Reference-Cited by-同舟云学术

Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience

Published:2013-03 Issue:2 Volume:18 Page:74-80
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Okamoto Akinao¹,Yanada Masamitsu¹,Inaguma Yoko¹,Tokuda Masutaka¹,Morishima Satoko¹,Kanie Tadaharu¹,Yamamoto Yukiya¹,Tsuzuki Motohiro¹,Akatsuka Yoshiki¹,Mizuta Shuichi¹,Okamoto Masataka¹,Emi Nobuhiko¹

Affiliation:

1. Department of HematologyFujita Health University School of Medicine, Toyoake, Japan

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1179/1607845412Y.0000000045

Reference24 articles.

1. Practical Utility of the Revised European-American Classification of Lymphoid Neoplasms for Japanese Non-Hodgkin's Lymphomas

2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

3. Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

4. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of Epstein–Barr virus DNA detection in pretreatment serum in diffuse large B‐cell lymphoma;Cancer Science;2015-10-07

2. The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients;Hematological Oncology;2015-07-14

3. Prevalence of Adverse Events to Radiopharmaceuticals from 2007 to 2011;Journal of Nuclear Medicine;2014-05-29

4. Detailed Analysis of Diffuse Large B Cell Lymphoma Patients: A Single-Center, Retrospective Study;ISRN Hematology;2013-07-30